GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Camurus AB (STU:7CA) » Definitions » Short Interest

Camurus AB (STU:7CA) Short Interest


View and export this data going back to 2019. Start your Free Trial

What is Camurus AB Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Camurus AB's Short Interest

For the Biotechnology subindustry, Camurus AB's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Camurus AB's Short Interest Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Camurus AB's Short Interest distribution charts can be found below:

* The bar in red indicates where Camurus AB's Short Interest falls into.


Camurus AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Camurus AB (STU:7CA) » Definitions » Short Interest
Comparable Companies
OSTO:BIOA B OSTO:FLERIE OSTO:VICO OSTO:GENO OSTO:EGTX OSTO:DMYD B OSTO:BINV OSTO:HNSA OSTO:XSPRAY OSTO:SYNACT VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX XBRU:UCB ALNY ONC BNTX XKRX:068270
Traded in Other Exchanges
CAMX:Sweden CAMXs:UK 0RD1:UK 7CA:Germany
Address
Ideon Science Park, Lund, SWE, SE-223 70
Website
https://www.camurus.com
Camurus AB is a research and development-focused pharmaceutical company. It develops pharmaceuticals for the treatment of serious and chronic diseases such as opioid addiction, pain, cancer, and endocrine diseases. The Camurus' clinical pipeline includes products for the treatment of dependence, pain, cancer and endocrine diseases, which are developed in-house and in collaboration with international pharmaceutical companies. The company's product pipeline includes CAM2029, CAM4072 and CAM2043.

Camurus AB Headlines

No Headlines